Mutation analysis of factor VIII in Korean patients with severe hemophilia A

被引:7
作者
You, Chur-Woo [5 ]
Son, Hee-Sook [5 ]
Kim, Hee Jin [4 ]
Woo, Eui-Jeon [3 ]
Kim, Soon-Ae [2 ]
Baik, Haing-Woon [1 ]
机构
[1] Eulji Univ, Sch Med, Dept Biochem & Mol Biol, Taejon 301832, South Korea
[2] Eulji Univ, Sch Med, Dept Pharmacol, Taejon 301832, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, Taejon, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Lab Med, Seoul, South Korea
[5] Eulji Univ, Sch Med, Dept Pediat, Taejon 301832, South Korea
关键词
Severe hemophilia A; Korean; Factor VIII; Mutation; INHIBITOR DEVELOPMENT; INVERSION HOTSPOT; MOLECULAR-BASIS; GENE; IDENTIFICATION; SITE; POLYMORPHISMS; RECOMBINANT; DIAGNOSIS; RESIDUES;
D O I
10.1007/s12185-010-0593-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophilia A is an X-linked recessive disorder caused by mutations of the factor VIII gene. The mutation spectrum has been reported in various populations, but not in Koreans. Mutation analysis of the factor VIII gene was performed in 22 unrelated Korean patients with severe hemophilia A. We extracted genomic DNA from their blood, and assessed intron inversions, deletions, and point mutations by direct DNA sequencing. A multiplex ligation-dependent probe amplification gene dosage assay was also performed to identify exon deletions. Disease-causing mutations were identified in all patients, of which four cases were previously unreported. Seven intron 22 inversions, nine point mutations (6 nonsense mutations and 3 missense mutations), and four small rearrangements were identified. One multi-exon deletion and one 5'-donor splicing site mutation were also observed. Four novel mutations (one small deletion, one multiple exon deletion, one missense, and one splice site mutation) were detected, and point mutations were predominant (40.9%), followed by intron 22 inversions (31.8%). Further studies are required in order to establish a solid conclusion regarding the prevalence of various mutations in the Korean population.
引用
收藏
页码:784 / 791
页数:8
相关论文
共 50 条
  • [1] Mutation analysis of factor VIII in Korean patients with severe hemophilia A
    Chur-Woo You
    Hee-Sook Son
    Hee Jin Kim
    Eui-Jeon Woo
    Soon-Ae Kim
    Haing-Woon Baik
    International Journal of Hematology, 2010, 91 : 784 - 791
  • [2] Factor VIII Intron 22 Inversion in Severe Hemophilia A Patients in Palestine
    Abu Arra, Caesar Mahmoud
    Samarah, Fekri
    Abu Hasan, Nael Sudqi
    SCIENTIFICA, 2020, 2020
  • [3] Inhibitors of Factor VIII in Black Patients with Hemophilia
    Viel, Kevin R.
    Ameri, Afshin
    Abshire, Thomas C.
    Iyer, Rathi V.
    Watts, Raymond G.
    Lutcher, Charles
    Channell, Cynthia
    Cole, Shelley A.
    Fernstrom, Karl M.
    Nakaya, Shelley
    Kasper, Carol K.
    Thompson, Arthur R.
    Almasy, Laura
    Howard, Tom E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16) : 1618 - 1627
  • [4] Factor VIII/factor IX prophylaxis for severe hemophilia
    Carcao, Manuel
    Srivastava, Alok
    SEMINARS IN HEMATOLOGY, 2016, 53 (01) : 3 - 9
  • [5] Factor VIII haplotypes in severe hemophilia A patients in India
    Patricia Pinto
    Kanjaksha Ghosh
    Shrimati Shetty
    Annals of Hematology, 2013, 92 : 999 - 1000
  • [6] Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States
    Neufeld, Ellis J.
    Sidonio, Robert F., Jr.
    O'Day, Ken
    Runken, M. Chris
    Meyer, Kellie
    Spears, Jeffrey
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 762 - 769
  • [7] Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII
    Lozier, Jay N.
    Kloos, Mark T.
    Merricks, Elizabeth P.
    Lemoine, Nathaly
    Whitford, Margaret H.
    Raymer, Robin A.
    Bellinger, Dwight A.
    Nichols, Timothy C.
    COMPARATIVE MEDICINE, 2016, 66 (05) : 405 - 411
  • [8] Genetic Characterization of the Factor VIII Gene in a Cohort of Colombian Patients with Severe Hemophilia A with Inhibitors
    Doncel, Samuel Sarmiento
    Mosquera, Gina Alejandra Diaz
    Pelaez, Ronald Guillermo
    Cortes, Javier Mauricio
    Rico, Carol Agudelo
    Cadavid, Francisco Javier Meza
    Plazas, Nelson Ramirez
    Amar, Ivan Alfredo Perdomo
    Siado, Jorge Enrique Pena
    Rey, Fabian Andres Parrado
    Montano, Cesar Alberto
    Villadiego, Alexys Maza
    HEMATOLOGY REPORTS, 2022, 14 (02) : 149 - 154
  • [9] The factor VIII treatment history of non-severe hemophilia A
    Abdi, Amal
    Kloosterman, Fabienne R.
    Eckhardt, Corien L.
    Male, Christoph
    Castaman, Giancarlo
    Fischer, Kathelijn
    Beckers, Erik A. M.
    Kruip, Marieke J. H. A.
    Peerlinck, Kathelijne
    Mancuso, Maria Elisa
    Santoro, Cristina
    Hay, Charles R.
    Platokouki, Helen
    van Der Bom, Johanna G.
    Gouw, Samantha C.
    Fijnvandraat, Karin
    Hart, Dan P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (12) : 3203 - 3210
  • [10] Evaluation of factor VIII prophylaxis of plasmatic origin in patients with severe hemophilia A
    Sambolino, Fabiana
    Medina, Vania
    Bentos, Jimena
    Torres, Rommel
    Berro, Maximiliano
    Canessa, Cecilia
    Rodriguez, Ismael
    Turcatti, Paola
    Insagaray, Juan
    REVISTA MEDICA DEL URUGUAY, 2022, 38 (04):